Search results
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 5 hours agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies in combating the virus ...
House Republicans’ Attempts to Attack Fauci Go Wildly Off Rails
The New Republic via Yahoo News· 3 days ago“You’re saying that you did not receive any of the $710 million?” she pressed. Fauci knew exactly...
Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'
Rolling Stone· 3 days agoA hearing in the House Oversight Committee once again devolved into chaos as Republican lawmakers...
Humans May Be Able to Grow New Teeth Within Just 6 Years
Popular Mechanics via Yahoo News· 3 days agoBack in 2021, scientists from the Kyoto University—who will also be involved in future human...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...
...Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with...
KOIN News 6 Portland· 3 days ago...that develops, manufactures and commercializes high-quality medicines for the treatment of...
How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?
Medscape· 1 day agoNew data on clazakizumab, a monoclonal antibody targeting interleukin-6 (IL-6), and home...
A Guide to Managing Covid This Summer
New York Times· 3 days agoHere’s what to know about symptoms, testing and treatment. KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers...
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Pharmaceutical Technology via Yahoo Finance· 2 days agoAlligator Bioscience released positive data from its Phase Ib/II OPTIMIZE-1 study (NCT04888312)...
Annexon shares leap as Guillain-Barré drug reduces disability in phase 3
FierceBiotech· 2 days agoAnnexon’s monoclonal antibody ANX005 reduced disability in patients with the rare autoimmune...